A personal therapy compartment includes a base of size to receive a human patient. The compartment includes a bed in the base said bed being made of a light transmissive material. An array of lights mounted is below the bed to transmit light onto a body supported on the bed. A control panel controls at least the wavelength, intensity and pulsation of the light.

Disclosures of the present invention describe a method for inhibiting melatonin secretion. In the present invention, an illumination device is particularly configured for emitting an illumination light with a specific wavelength that is in a range between 581 nm and 590 nm, and a variety of experimental data have proved that the illumination light functions as a melatonin secretion inhibitor. Therefore, the illumination device of the present invention is evidenced to be suitable for use in light therapy, so as to treat seasonal affective disorder (SAD) by way of inhibiting melatonin secretion. Briefly speaking, after a SAD patient receives the irradiation of the illumination light having wavelength ranged in 581-590 nm for a treatment course, the SAD patient is eventually leaded to stay in good spirits and a stable condition of emotion, thereby curing the abnormal symptoms of sleepiness and emotional disorder.

This present invention and its embodiments relates to methods for reducing pain during photodynamic therapy of actinic keratosis. The present invention also relates to methods of treating actinic keratosis with reduced pain during photodynamic therapy of actinic keratosis.

A spectral power distribution (SPD) fusion lighting apparatus includes a first visible light source with a first SPD, a second visible light source with a second SPD, a driver circuit, and a controller. The first SPD is different than the second SPD markedly in a 50 nm wavelength range. The controller toggles the turning on of the first visible light and the second visible light at a frequency greater than 25 Hz. The first visible light source is turned on during one half of the duty cycle, whereas the second visible light source is turned on during the other half of the duty cycle. The first visible light source and the second visible light emit similar light outputs and have similar chromaticity coordinates on the CIE 1931 color space chromaticity diagram. In some embodiments a sound wave generator is used to generate a sound wave at the same frequency.

A method is provided for performing electromagnetic radiation therapy on a subject. The method comprises providing a device which emits electromagnetic radiation, wherein the electromagnetic radiation includes a first portion that oscillates between at least first and second distinct states, and a second non-oscillatory portion; and illuminating the subject with the electromagnetic radiation.

A facial skin disorder (FSD) identification system is provided and includes a sliding rail arranged around a human facial epidermis, a carrier arranged on the sliding rail, at least one image capturing device arranged on the carrier, and a control circuit unit arranged on the carrier for the carrier to move on the sliding rail and the image capturing device to capture images of the human facial epidermis.

The subject matter of the invention is a therapeutic device in the form of a cylindrical chamber which comprises a hyperbaric chamber, LED matrices (5) and inductive coil rings (10, 11, 12, 13), constructed in one inseparable set in the form of a chamber of 200-280 cm in length and diameter of the round cylinder (70-130 cm).

A subject of the invention is the source of LED lighting that improves human cognitive performance during work activities or in any activity and simulates sun radiation in the biologically beneficial range 460 to 660 nm, for more than 90%. The whole system of the LED lighting source is set in such a way that 4.5 to 6% of blue and turquoise light radiation is added to the light radiation emitted from white LED chips, and it is advantageous if of equal radiation intensity. This measurement will provide for balancing of radiation intensity to 90% of the sunshine level. The generated combined light radiation of the cognitive LED lighting source has CRI 98 and correlated colour temperature 4000 to 4700 K, the sun radiation has correlated colour temperature 4982 K and CRI 99.5.

The present disclosure describes a wellness application for digital usage comprising at least one software program that identifies the level of high energy visible light reduction provided by the thin film; and a dosimeter for sending data about ionizing radiation to the software. The software tracks the total time of device usage and determines wherein the software, based on a dosimeter measurement received from the dosimeter, communicates with at least one processor to execute at least one of: determine a notification for reducing exposure to high energy visible blue light about divide user interface, and adjust the display output by at least one of adjusting a color contrast and brightness, taking into account the level of visible light coverage and total time of device usage.

The disclosure relates to a device and a method for the treatment of diseases of the skin, glands, mucousae, connective tissue, nerves and/or horny tissue. The device is adapted for the treatment of diseases of the skin, glands, mucousae, connective tissue, nerves and/or horny tissue and has at least one applicator, which applicator is arranged outside the device housing; at least one radio wave module, which radio wave module is adapted to generate an adjustable electromagnetic radiation with a variable frequency or with at least one constant frequency with an adjustable variable or at least one adjustable constant intensity.